These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8347133)

  • 21. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients.
    Hamada Y; Kitoh R; Raskin P
    Diabetes; 1991 Oct; 40(10):1233-40. PubMed ID: 1936586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maturation of aldose reductase expression in the neonatal rat inner medulla.
    Schwartz GJ; Zavilowitz BJ; Radice AD; Garcia-Perez A; Sands JM
    J Clin Invest; 1992 Oct; 90(4):1275-83. PubMed ID: 1401064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldose reductase localization in human retinal mural cells.
    Akagi Y; Kador PF; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1516-9. PubMed ID: 6417042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose and aldehyde reductases in human tissues.
    Srivastava SK; Ansari NH; Hair GA; Das B
    Biochim Biophys Acta; 1984 Aug; 800(3):220-7. PubMed ID: 6432055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The level of erythrocyte aldose reductase is associated with the severity of diabetic retinopathy.
    Nishimura C; Hotta Y; Gui T; Seko A; Fujimaki T; Ishikawa T; Hayakawa M; Kanai A; Saito T
    Diabetes Res Clin Pract; 1997 Sep; 37(3):173-7. PubMed ID: 9306038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of aldose reductase from human placenta and stabilization of the inhibitor binding site.
    Vander Jagt DL; Stangebye LA; Hunsaker LA; Eaton RP; Sibbitt WL
    Biochem Pharmacol; 1988 Mar; 37(6):1051-6. PubMed ID: 3128293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between erythrocyte aldose reductase level and human diabetic retinopathy.
    Oishi N; Kubo E; Takamura Y; Maekawa K; Tanimoto T; Akagi Y
    Br J Ophthalmol; 2002 Dec; 86(12):1363-6. PubMed ID: 12446366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of aldose reductase from the thick ascending limb of Henle's loop of rabbit kidney.
    Grunewald RW; Eckstein A; Reisse CH; Müller GA
    Nephron; 2001 Sep; 89(1):73-81. PubMed ID: 11528236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrelationships among human aldo-keto reductases: immunochemical, kinetic and structural properties.
    Srivastava SK; Das B; Hair GA; Gracy RW; Awasthi S; Ansari NH; Petrash JM
    Biochim Biophys Acta; 1985 Jul; 840(3):334-43. PubMed ID: 3924115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical localization of aldose reductase. II. Rat eye and kidney.
    Ludvigson MA; Sorenson RL
    Diabetes; 1980 Jun; 29(6):450-9. PubMed ID: 6769730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes.
    Takahashi M; Fujii J; Miyoshi E; Hoshi A; Taniguchi N
    Int J Cancer; 1995 Sep; 62(6):749-54. PubMed ID: 7558425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte aldose reductase protein: a clue to elucidate risk factors for diabetic neuropathies independent of glycemic control.
    Takahashi Y; Tachikawa T; Ito T; Takayama S; Omori Y; Iwamoto Y
    Diabetes Res Clin Pract; 1998 Nov; 42(2):101-7. PubMed ID: 9886746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning and expression of human aldose reductase.
    Nishimura C; Matsuura Y; Kokai Y; Akera T; Carper D; Morjana N; Lyons C; Flynn TG
    J Biol Chem; 1990 Jun; 265(17):9788-92. PubMed ID: 2112546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
    O'connor T; Ireland LS; Harrison DJ; Hayes JD
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pterin-7-carboxamides as a new class of aldose reductase inhibitors.
    Saito R; Suzuki S; Sasaki K
    Bioorg Med Chem Lett; 2016 Oct; 26(20):4870-4874. PubMed ID: 27666634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of aldose reductase by nonenzymatic glycosylation.
    Srivastava SK; Ansari NH; Bhatnagar A; Hair G; Liu S; Das B
    Prog Clin Biol Res; 1989; 304():171-84. PubMed ID: 2506561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased erythrocyte aldose reductase activity in type 1 diabetic patients.
    Hamada Y; Kito R; Raskin P
    Diabet Med; 1991 Apr; 8(3):226-31. PubMed ID: 1828737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.